News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,565 Results
Type
Article (42157)
Company Profile (436)
Press Release (668972)
Section
Business (208672)
Career Advice (2021)
Deals (36001)
Drug Delivery (103)
Drug Development (83536)
Employer Resources (173)
FDA (16400)
Job Trends (15083)
News (352645)
Policy (33043)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (8)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (6)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2635)
Accelerated approval (3)
Adcomms (24)
Allergies (82)
Alliances (50888)
ALS (86)
Alzheimer's disease (1395)
Antibody-drug conjugate (ADC) (122)
Approvals (16387)
Artificial intelligence (241)
Autoimmune disease (16)
Automation (14)
Bankruptcy (371)
Best Places to Work (11841)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (330)
Bladder cancer (61)
Brain cancer (24)
Breast cancer (252)
Cancer (2012)
Cardiovascular disease (158)
Career advice (1686)
Career pathing (29)
CAR-T (146)
Cell therapy (415)
Cervical cancer (17)
Clinical research (67440)
Collaboration (800)
Compensation (452)
Complete response letters (23)
COVID-19 (2640)
CRISPR (39)
C-suite (214)
Cystic fibrosis (103)
Data (1925)
Decentralized trials (2)
Denatured (26)
Depression (44)
Diabetes (246)
Diagnostics (6386)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (115)
Drug pricing (104)
Drug shortages (26)
Duchenne muscular dystrophy (90)
Earnings (87358)
Editorial (35)
Employer branding (21)
Employer resources (147)
Events (115110)
Executive appointments (642)
FDA (17507)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (716)
Gene editing (102)
Generative AI (19)
Gene therapy (295)
GLP-1 (716)
Government (4465)
Grass and pollen (4)
Guidances (48)
Healthcare (19134)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2771)
Inflammatory bowel disease (138)
Inflation Reduction Act (11)
Influenza (47)
Intellectual property (84)
Interviews (311)
IPO (16766)
IRA (43)
Job creations (3699)
Job search strategy (1434)
Kidney cancer (9)
Labor market (34)
Layoffs (477)
Leadership (16)
Legal (7976)
Liver cancer (71)
Lung cancer (293)
Lymphoma (131)
Machine learning (2)
Management (58)
Manufacturing (273)
MASH (62)
Medical device (13463)
Medtech (13468)
Mergers & acquisitions (19693)
Metabolic disorders (654)
Multiple sclerosis (69)
NASH (19)
Neurodegenerative disease (88)
Neuropsychiatric disorders (30)
Neuroscience (1890)
NextGen: Class of 2025 (6754)
Non-profit (4546)
Northern California (2413)
Now hiring (37)
Obesity (358)
Opinion (220)
Ovarian cancer (73)
Pain (79)
Pancreatic cancer (77)
Parkinson's disease (136)
Partnered (18)
Patents (202)
Patient recruitment (94)
Peanut (47)
People (58428)
Pharmaceutical (86)
Pharmacy benefit managers (19)
Phase I (21187)
Phase II (29761)
Phase III (22006)
Pipeline (984)
Podcasts (73)
Policy (115)
Postmarket research (2601)
Preclinical (9041)
Press Release (67)
Prostate cancer (94)
Psychedelics (37)
Radiopharmaceuticals (260)
Rare diseases (374)
Real estate (6008)
Recruiting (66)
Regulatory (22573)
Reports (46)
Research institute (2412)
Resumes & cover letters (351)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (69)
Series A (129)
Series B (83)
Service/supplier (11)
Sickle cell disease (54)
Southern California (2097)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (29)
Startups (3757)
State (2)
Stomach cancer (13)
Supply chain (60)
The Weekly (44)
United States (21401)
Vaccines (671)
Venture capitalists (38)
Webinars (13)
Weight loss (244)
Women's health (35)
Worklife (16)
Date
Today (132)
Last 7 days (576)
Last 30 days (2744)
Last 365 days (34534)
2025 (7847)
2024 (36301)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54920)
2019 (47416)
2018 (35696)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29221)
2011 (29863)
2010 (27992)
Location
Africa (735)
Alabama (54)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (39095)
Australia (6507)
California (5569)
Canada (1864)
China (476)
Colorado (251)
Connecticut (268)
Delaware (126)
Europe (85345)
Florida (813)
Georgia (190)
Idaho (57)
Illinois (506)
India (23)
Indiana (292)
Iowa (10)
Japan (140)
Kansas (103)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (843)
Massachusetts (4253)
Michigan (210)
Minnesota (372)
Mississippi (2)
Missouri (76)
Montana (29)
Nebraska (25)
Nevada (56)
New Hampshire (66)
New Jersey (1579)
New Mexico (30)
New York (1583)
North Carolina (974)
North Dakota (7)
Northern California (2413)
Ohio (193)
Oklahoma (14)
Oregon (37)
Pennsylvania (1252)
Puerto Rico (9)
Rhode Island (27)
South America (1108)
South Carolina (18)
South Dakota (1)
Southern California (2097)
Tennessee (92)
Texas (828)
Utah (166)
Virginia (131)
Washington D.C. (59)
Washington State (525)
West Virginia (3)
Wisconsin (49)
711,565 Results for "serina therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting
March 25, 2025
·
3 min read
Press Releases
Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
March 24, 2025
·
13 min read
Press Releases
Serina Therapeutics Announces Sale of UniverXome Subsidiary
January 16, 2025
·
5 min read
Press Releases
Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors
February 12, 2025
·
4 min read
Press Releases
Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors
January 14, 2025
·
5 min read
Business
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
Serina Therapeutics, Inc., a clinical-stage biotechnology company focused on developing its proprietary POZ PlatformTM drug delivery technology announced the appointment of Dr. Simba Gill as Executive Chairman.
April 17, 2024
·
4 min read
Press Releases
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
December 12, 2024
·
3 min read
Deals
Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics
Serina Therapeutics (NYSE American: SER), a clinical-stage biotechnology company developing a pipeline of therapies for the treatment of Parkinson’s Disease and other neurological diseases, today announced the closing of its previously announced merger with a wholly-owned subsidiary of AgeX Therapeutics, Inc.
March 26, 2024
·
12 min read
BioMidwest
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
Enable Injections, Inc. and Serina Therapeutics announced a partnership to develop and commercialize SER-252 in combination with enFuse for the treatment of Parkinson’s disease.
May 15, 2024
·
6 min read
Press Releases
Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson’s Disease Patients
February 3, 2025
·
5 min read
1 of 71,157
Next
